Clinical Trials

NCT05038553 | ACTIVE_NOT_RECRUITING
125 participants

Chronic Pain in Rheumatoid Arthritis

Study Type:
OBSERVATIONAL
Last Updated:
2026-05-28
Start Date:
2021-10-12
Completion:
2027-02-28
Conditions
  • Arthritis, Rheumatoid
  • Pain
Interventions
  • OTHER
No Results Yet
NCT04924075 | RECRUITING | PHASE2
322 participants

Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-28
Start Date:
2021-08-12
Completion:
2029-06-04
Conditions
  • Pheochromocytoma/Paraganglioma
  • Pancreatic Neuroendocrine Tumor
  • Von Hippel-Lindau Disease
  • Advanced Gastrointestinal Stromal Tumor
  • HIF-2α Mutated Cancers
Interventions
  • DRUG
No Results Yet
NCT04794530 | RECRUITING | PHASE3
190 participants

The COCOA-PAD II Trial

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-28
Start Date:
2021-11-19
Completion:
2026-12-31
Conditions
  • Peripheral Artery Disease
Interventions
  • DRUG
No Results Yet
NCT04640779 | COMPLETED | PHASE1
22 participants

Low-Dose Selinexor and Choline Salicylate for Non-Hodgkin or Hodgkin Lymphoma, Histiocytic/Dendritic Cell Neoplasm, or Relapsed or Refractory Multiple Myeloma

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-28
Start Date:
2021-02-08
Completion:
2025-11-19
Conditions
  • Recurrent Histiocytic and Dendritic Cell Neoplasm
  • Recurrent Hodgkin Lymphoma
  • Recurrent Non-Hodgkin Lymphoma
  • Recurrent Plasma Cell Myeloma
  • Refractory Histiocytic and Dendritic Cell Neoplasm
  • Refractory Hodgkin Lymphoma
  • Refractory Non-Hodgkin Lymphoma
  • Refractory Plasma Cell Myeloma
Interventions
  • DRUG
No Results Yet
NCT04514484 | ACTIVE_NOT_RECRUITING | PHASE1
8 participants

Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-28
Start Date:
2021-11-22
Completion:
2024-11-11
Conditions
  • Advanced Differentiated Thyroid Gland Carcinoma
  • Advanced Head and Neck Carcinoma
  • Advanced Hepatocellular Carcinoma
  • Advanced Kaposi Sarcoma
  • Advanced Lung Non-Small Cell Carcinoma
  • Advanced Lung Small Cell Carcinoma
  • Advanced Malignant Solid Neoplasm
  • Advanced Melanoma
  • Advanced Ovarian Carcinoma
  • Advanced Prostate Carcinoma
  • Advanced Renal Cell Carcinoma
  • Advanced Thyroid Gland Medullary Carcinoma
  • Advanced Triple-Negative Breast Carcinoma
  • Advanced Urothelial Carcinoma
  • Anatomic Stage III Breast Cancer AJCC v8
  • Anatomic Stage IV Breast Cancer AJCC v8
  • Castration-Resistant Prostate Carcinoma
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • HIV Infection
  • Metastatic Differentiated Thyroid Gland Carcinoma
  • Metastatic Head and Neck Carcinoma
  • Metastatic Hepatocellular Carcinoma
  • Metastatic Kaposi Sarcoma
  • Metastatic Lung Non-Small Cell Carcinoma
  • Metastatic Lung Small Cell Carcinoma
  • Metastatic Malignant Solid Neoplasm
  • Metastatic Melanoma
  • Metastatic Ovarian Carcinoma
  • Metastatic Prostate Carcinoma
  • Metastatic Renal Cell Carcinoma
  • Metastatic Thyroid Gland Medullary Carcinoma
  • Metastatic Triple-Negative Breast Carcinoma
  • Metastatic Urothelial Carcinoma
  • Recurrent Differentiated Thyroid Gland Carcinoma
  • Recurrent Head and Neck Carcinoma
  • Recurrent Hepatocellular Carcinoma
  • Recurrent Kaposi Sarcoma
  • Recurrent Lung Non-Small Cell Carcinoma
  • Recurrent Lung Small Cell Carcinoma
  • Recurrent Malignant Solid Neoplasm
  • Recurrent Melanoma
  • Recurrent Ovarian Carcinoma
  • Recurrent Prostate Carcinoma
  • Recurrent Renal Cell Carcinoma
  • Recurrent Thyroid Gland Medullary Carcinoma
  • Recurrent Triple-Negative Breast Carcinoma
  • Recurrent Urothelial Carcinoma
  • Refractory Differentiated Thyroid Gland Carcinoma
  • Stage III Differentiated Thyroid Gland Carcinoma AJCC v8
  • Stage III Hepatocellular Carcinoma AJCC v8
  • Stage III Lung Cancer AJCC v8
  • Stage III Ovarian Cancer AJCC v8
  • Stage III Prostate Cancer AJCC v8
  • Stage III Renal Cell Cancer AJCC v8
  • Stage III Thyroid Gland Medullary Carcinoma AJCC v8
  • Stage IV Differentiated Thyroid Gland Carcinoma AJCC v8
  • Stage IV Hepatocellular Carcinoma AJCC v8
  • Stage IV Lung Cancer AJCC v8
  • Stage IV Ovarian Cancer AJCC v8
  • Stage IV Prostate Cancer AJCC v8
  • Stage IV Renal Cell Cancer AJCC v8
  • Stage IV Thyroid Gland Medullary Carcinoma AJCC v8
Interventions
  • PROCEDURE
  • DRUG
  • BIOLOGICAL
NCT04469959 | COMPLETED | PHASE2
79 participants

Dopaminergic Dysfunction in Late-Life Depression

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-28
Start Date:
2021-02-15
Completion:
2026-04-29
Conditions
  • Late Life Depression
  • Cognitive Decline
  • Depressive Disorder, Treatment-Resistant
  • Levodopa
  • Gait Impairment
Interventions
  • DRUG
No Results Yet
NCT04216316 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2
12 participants

Testing the Addition of an Anti-cancer Drug, Berzosertib (M6620, VX-970), to the Usual Treatments (Carboplatin and Gemcitabine) and to Pembrolizumab for Patients With Advanced Squamous Cell Non-small Cell Lung Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-28
Start Date:
2021-04-14
Completion:
2024-03-31
Conditions
  • Lung Non-Small Cell Squamous Carcinoma
  • Stage IV Lung Cancer AJCC v8
Interventions
  • DRUG
  • PROCEDURE
  • BIOLOGICAL
Previous
Sorted by latest updates
Next
Showing 40 trials per page